Actively Recruiting
Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Led by University Hospital Padova · Updated on 2025-03-25
580
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer
CONDITIONS
Official Title
Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical suspicion of prostate cancer due to elevated prostate specific antigen and/or suspicious digital rectal exam
- At least one suspicious prostate lesion on MRI with a Prostate Imaging-Reporting and Data System score of 3 or higher before biopsy
You will not qualify if you...
- Patients currently under active surveillance or previously diagnosed with prostate cancer before biopsy
- Previous radiotherapy to the prostate for cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Urology Unit - Padua University Hospital
Padua, Italy, Italy, 35100
Actively Recruiting
Research Team
F
Fabio F. Zattoni, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here